Althealth

Femarelle Femarelle Natural Menopause bonehealth (56 caps)

Barcode: 5035883004505 Product code: 66257 BIN number: 22385

Menopause, although a natural phenomena in a woman?s life, is very often accompanied by disturbing side effects in the form of vasomotor, psychological and metabolic complaints, as well as significant health issues such as cardiovascular diseases and bone loss leading to osteopenia and osteoporosis.

£26.99

*Additional shipping charges apply outside the UK. Please refer to our delivery page.

Special offers

  • Buy 6 for the Price of 5
  • Free UK shipping

Only one offer applies at a time, the one that gives you the biggest discount will automatically be applied to your basket.

Femarelle 
Femarelle Natural Menopause bonehealth 
(56 caps)
Product supplied will always be the latest version so may differ from the image shown.
Product Price Quantity Add to cart 6 for 5
Femarelle Femarelle Natural Menopause bonehealth (56 caps) £26.99

View all products by Femarelle

Femarelle Femarelle Natural Menopause bonehealth overview

Menopause, although a natural phenomena in a woman?s life, is very often accompanied by disturbing side effects in the form of vasomotor, psychological and metabolic complaints, as well as significant health issues such as cardiovascular diseases and bone loss leading to osteopenia and osteoporosis.

Further information about Femarelle Femarelle Natural Menopause bonehealth

Menopause, although a natural phenomena in a woman?s life, is very often accompanied by disturbing side effects in the form of vasomotor, psychological and metabolic complaints, as well as significant health issues such as cardiovascular diseases and bone loss leading to osteopenia and osteoporosis.
The recent barrage of publications pointing to increased health risks associated with hormone therapy has caused an upheaval in the women's health sector. As a result, a large gap has opened up in the provision of safe solutions for the integrative therapy of menopausal symptoms and bone health (osteopenia).
The essential requirements for a therapy are focused today on two levels.
? Efficacy: A solution that effectively manages the menopause transition by providing relief of menopausal symptoms while treating osteopenia.
? Safety: Use of recognized safety markers that serve as a warning for increased risk factors, thus providing a treatment option that is safe both in the short and in the long term.
Slowing the process of bone loss while alleviating menopausal symptoms requires a therapy that targets the physiological mechanisms affected by estrogen. For such a therapy to be safe, however, it must be selective.
The ultimate therapeutic concept for fulfilling these needs is a novel Selective Estrogen Receptor Modulator (SERM) that affects estrogen receptors only in specific sites, without affecting tissues where any change can have dangerous consequences.
Femarelle? (DT56a) is a product based on this concept.
Clinical and pre-clinical studies have shown that Femarelle? exerts agonistic (stimulatory) activity on the estrogen receptors that control menopausal symptoms and the process of bone build-up, while having an antagonistic (blocking) effect on estrogen receptors in the breast and the uterus. In other words, Femarelle? acts as a novel SERM.
The results of the above mentioned studies clearly show and prove that Femarelle? successfully meets both the efficacy and safety requirements, and thus provides women with a safe and effective integrative solution for the relief of menopausal symptoms and the treatment of osteopenia.
In the year 2000, Femarelle? has started its commercialization stage and consumers around the world have started to enjoy the benefits that it provides. Today Femarelle? can be found in over 12 countries (also available as Tofupill and Bonfemi).
Femarelle?'s uniqueness lies in its being a Selective Estrogen Receptor Modulator- a SERM. The selectivity in the estrogen receptor bondage provides both menopausal symptoms relief and bone health, without affecting the sensitive tissues in the breast and uterus.
Thus, Femarelle? provides a safe and effective solution for the management of menopause.
The scientific activity surrounding Femarelle? provides published studies in leading scientific journals worldwide, as well as international recognition and acceptance by the medical community both in practice and in leading medical conventions (list of published articles and medical congresses). The research process continues and new studies are constantly being conducted in order to provide comprehensive data proving both the efficacy and safety of use of the product.

Product Information
Name of product: Femarelle?
Composition: Each capsule contains 322 mg. of DT56a (a unique compound from botanical source) and 108 mg. of flaxseed (adjuvant).
Recommended use: Femarelle? is intended for women from the time they reach peri-menopause and onward. The therapeutic indication is the relief of menopausal symptoms and bone health.
Recommended intake: 1 capsule twice daily morning and evening; can be taken with or without food.
Femarelle? is a clinically proven treatment with published studies in leading medical journals.
Published studies have shown:
Efficacy of Femarelle?
? Femarelle? combines menopausal symptoms relief and bone health.
? High efficacy:
? Relief is felt within the first week of treatment (avg. 5-7 days).
? Symptoms relief is felt by 3 out of 4 women.
? Hot flushes relief in 76% of the women.
? Joint and muscle pain relief in 70% of the women.
? Headache relief in 68% of the women.
? Femarelle? increases Bone Mineral Density (BMD).
? Following 12 months of treatment an increase in BMD of 3.6% in the spine and 2.0% in the hip.
? Femarelle? exhibits unique bone-forming properties by increasing bone formation through osteoblast activity, thus inducing bone rejuvenation.
Safety of Femarelle?
Femarelle? was shown to work in a selective manner on the target tissues and thus:
? Femarelle? does not affect the breast tissue.
? Femarelle? does not affect the uterus and the endometria.
? Femarelle? does not affect the Thyroid Stimulating Hormone (TSH).
? Femarelle? does not affect liver and kidney functions.
? Femarelle? does not affect the hormonal blood profile.
? Femarelle? does not induce proliferation of hormone dependant breast cancer cells.
? Furthermore, in the studies and in the data accumulated up to date no serious adverse events have been reported.

Femarelle Femarelle Natural Menopause bonehealth ingredients

Each capsule contains 322 mg. of DT56a (a unique compound from botanical source) and 108 mg. of flaxseed (adjuvant).

Femarelle Femarelle Natural Menopause bonehealth nutritional benefits

Femarelle menopause or bone healths dietary supplement capsules For your hot flashes and mood swings. Sleep disturbances and loss of libido.

How to use Femarelle Femarelle Natural Menopause bonehealth

1 capsule twice daily morning and evening; can be taken with or without food.

Femarelle Femarelle Natural Menopause bonehealth warnings

Keep out of reach from children.
Femarelle? was shown to work in a selective manner on the target tissues and thus:
? Femarelle? does not affect the breast tissue.
? Femarelle? does not affect the uterus and the endometria.
? Femarelle? does not affect the Thyroid Stimulating Hormone (TSH).
? Femarelle? does not affect liver and kidney functions.
? Femarelle? does not affect the hormonal blood profile.
? Femarelle? does not induce proliferation of hormone dependant breast cancer cells.
? Furthermore, in the studies and in the data accumulated up to date no serious adverse events have been reported.

We ship out to the UK, EU and all over the world. In the UK, and reduced shipping on all orders over £35. We have a special offer of 'Buy 5, get 1 free' some of our special offers are even better than this with 'Buy 3 get 1 free', 'Buy 2, get 1 free' and even 'BOGOF' (Buy 1, get 1 free) on selected products. View our special offers page for full details.

© AltHealth 2020 | All rights reserved | Site by Cultrix